FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026 CAMBRIDGE, MA / ACCESS Newswire / June...
MOORE, Okla., June 18, 2026 /PRNewswire/ -- Why do veterinary costs in Oklahoma vary so widely between clinics? According to a...
MOORE, Okla., June 18, 2026 /PRNewswire/ -- Why do veterinary costs in Oklahoma vary so widely between clinics? According to a...
Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all...
CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its...
Louvain-la-Neuve, Belgium, 17 June 2026 - At its Board meeting held yesterday in Louvain-la-Neuve, IBA (Ion Beam Applications S.A., EURONEXT)...
Alongside, by TimelyCare, analyzes 1 million+ student interactions to reveal critical trends in belonging, motivation, and attendance 2026 Youth Wellness...
PHILADELPHIA, June 16, 2026 /PRNewswire/ -- The Pew Charitable Trusts today announced the 2026 class of the Pew Latin American...
Arizton report highlights smart PPE adoption, industrial safety trends, regional growth opportunities, competitive benchmarking, and market forecasts through 2031.CHICAGO, June...
Global collaboration leverages AI to address knowledge and access barriers in India, Indonesia, and ThailandBOSTON, June 16, 2026 /PRNewswire/ --...
Global collaboration leverages AI to address knowledge and access barriers in India, Indonesia, and ThailandBOSTON, June 16, 2026 /PRNewswire/ --...
Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran...
PALO ALTO, CA / ACCESS Newswire / June 16, 2026 / Bioz, Inc., an innovative platform focused on extracting and...
SHELTON, CT / ACCESS Newswire / June 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1...
COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its...
Two of the world's most experienced emergency responders, the Uganda Red Cross Society and Doctors Without Borders, will each receive...
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today...
SOUTH SAN FRANCISCO, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a...
82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase...